![](https://www.diabetesnews.com/wp-content/uploads/2014/03/byetta-diabetes-drug-150x150.jpg)
The pre-filled, single-use pen injector eliminates the need for patients to transfer the medication between a vial and a syringe. It contains the same formulation and dose as the original Bydureon single-dose tray, providing the same continuous release of exenatide.
Read more